Physician profile
Anuj Chawla
NPI 1083841027
$1,240.21
in general payments reported to CMS, 2019-2025
8 companies · $32.63 in 2025
The $32.63 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $410 · 2021: $219 · 2022: $43.40 · 2023: $70.59 · 2025: $32.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $103.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alimera Sciences, INC. | $654.63 | 2019-2022 | |
| Genentech USA, INC. | $223.62 | 2019-2025 | Vabysmo |
| Novartis Pharmaceuticals Corporation | $178.94 | 2019 | |
| Coherus Oncology, INC. | $70.59 | 2023 | |
| Mallinckrodt Hospital Products INC. | $43.55 | 2021 | |
| Vyera Pharmaceuticals, LLC | $24.62 | 2021 | |
| Tearlab Corp | $23.95 | 2021 | |
| Allergan, INC. | $20.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anuj Chawla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.